Association between dietary Vitamin C intake and non-alcoholic fatty liver disease: A cross-sectional study among middle-aged and older adults

PLoS ONE

Volumn 11, Issue 1, 2016, Pages

  Wei, Jie ^a,b   Lei, Guang Hua ^a   Fu, Lei ^a   Zeng, Chao ^a   Yang, Tuo ^a   Peng, Shi Fang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; ANTIOXIDANT; VITAMIN;

ADULT; AGED; ARTICLE; CHINESE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; OBESITY; SEX DIFFERENCE; VITAMIN INTAKE; ANALYSIS; CALORIC INTAKE; COMPLICATION; DIETARY SUPPLEMENT; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; ODDS RATIO; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; ASCORBIC ACID; CROSS-SECTIONAL STUDIES; DIETARY SUPPLEMENTS; ENERGY INTAKE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; ODDS RATIO; RISK FACTORS; VITAMINS;

EID: 84958213220     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0147985     Document Type: Article

References (48)

1. Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015; 313: 2263-2273. doi: 10.1001/jama.2015.5370 PMID: 26057287
2. Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005; 41: 1313-1321. PMID: 15915461
3. Lirussi F, Azzalini L, Orando S, Orlando R, Angelico F. Antioxidant supplements for non-alcoholic fatty liver disease and/or steatohepatitis. Cochrane Database Syst Rev. 2007: D4996.
4. Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, Contreras M, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011; 140: 124-131. doi: 10.1053/j.gastro.2010.09.038 PMID: 20858492
5. Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012; 142: 1592-1609. doi: 10.1053/j.gastro.2012.04.001 PMID: 22656328
6. Li Z, Xue J, Chen P, Chen L, Yan S, Liu L. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 2014; 29: 42-51. doi: 10.1111/jgh.12428 PMID: 24219010
7. Polimeni L, Del BM, Baratta F, Perri L, Albanese F, Pastori D, et al. Oxidative stress: New insights on the association of non-alcoholic fatty liver disease and atherosclerosis. World J Hepatol. 2015; 7: 1325-1336. doi: 10.4254/wjh.v7.i10.1325 PMID: 26052378
8. Bian S, Gao Y, Zhang M, Wang X, Liu W, Zhang D, et al. Dietary nutrient intake and metabolic syndrome risk in Chinese adults: a case-control study. Nutr J. 2013; 12: 106. doi: 10.1186/1475-2891-12-106 PMID: 23898830
9. Li Y, Guo H, Wu M, Liu M. Serum and dietary antioxidant status is associated with lower prevalence of the metabolic syndrome in a study in Shanghai, China. Asia Pac J Clin Nutr. 2013; 22: 60-68. doi: 10. 6133/apjcn.2013.22.1.06 PMID: 23353612
10. Motamed S, Ebrahimi M, Safarian M, Ghayour-Mobarhan M, Mouhebati M, Azarpazhouh M, et al. Micronutrient intake and the presence of the metabolic syndrome. N Am J Med Sci. 2013; 5: 377-385. doi: 10.4103/1947-2714.114171 PMID: 23923113
11. Ford ES, Mokdad AH, Giles WH, Brown DW. The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes. 2003; 52: 2346-2352. PMID: 12941775
12. Sun C Nutrition and food hygiene. Beijing, China.: People's Medical Publishing House; 2013.
13. Buettner GR. The pecking order of free radicals and antioxidants: lipid peroxidation, alpha-tocopherol, and ascorbate. Arch Biochem Biophys. 1993; 300: 535-543. PMID: 8434935
14. Ipsen DH, Tveden-Nyborg P, Lykkesfeldt J. Does vitamin C deficiency promote fatty liver disease development? Nutrients. 2014; 6: 5473-5499. doi: 10.3390/nu6125473 PMID: 25533004
15. Musso G, Gambino R, De Michieli F, Cassader M, Rizzetto M, Durazzo M, et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology. 2003; 37: 909-916. PMID: 12668986
16. Han JM, Jo AN, Lee SM, Bae HS, Jun DW, Cho YK, et al. Associations between intakes of individual nutrients or whole food groups and non-alcoholic fatty liver disease among Korean adults. J Gastroenterol Hepatol. 2014; 29: 1265-1272. PMID: 24955455
17. Da SH, Arendt BM, Noureldin SA, Therapondos G, Guindi M, Allard JP. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls. J Acad Nutr Diet. 2014; 114: 1181-1194. doi: 10.1016/j.jand.2014.01.009 PMID: 24631112
18. Madan K, Bhardwaj P, Thareja S, Gupta SD, Saraya A. Oxidant stress and antioxidant status among patients with nonalcoholic fatty liver disease (NAFLD). J Clin Gastroenterol. 2006; 40: 930-935. PMID: 17063114
19. Wei J, Zeng C, Gong QY, Yang HB, Li XX, Lei GH, et al. The association between dietary selenium intake and diabetes: a cross-sectional study among middle-aged and older adults. Nutr J. 2015; 14: 18. doi: 10.1186/s12937-015-0007-2 PMID: 25880386
20. Wei J, Zeng C, Gong QY, Li XX, Lei GH, Yang TB. Associations between Dietary Antioxidant Intake and Metabolic Syndrome. PLoS One. 2015; 10: e130876.
21. Zeng C, Wei J, Li H, Yang T, Zhang FJ, Pan D, et al. Relationship between Serum Magnesium Concentration and Radiographic Knee Osteoarthritis. J Rheumatol. 2015; 42: 1231-1236. doi: 10.3899/jrheum.141414 PMID: 26034158
22. Zeng C, Li H, Wei J, Yang T, Deng ZH, Yang Y, et al. Association between Dietary Magnesium Intake and Radiographic Knee Osteoarthritis. PLoS One. 2015; 10: e127666.
23. [Guidelines for diagnosis and treatment of nonalcoholic fatty liver diseases]. Zhonghua Gan Zang Bing Za Zhi. 2006; 14: 161-163. PMID: 16700132
24. Yang Y Chinese Food Composition Table. Beijing, China: Peking University Medical Press; 2009.
25. Chan R, Wong VW, Chu WC, Wong GL, Li LS, Leung J, et al. Higher estimated net endogenous Acid production may be associated with increased prevalence of nonalcoholic Fatty liver disease in chinese adults in Hong Kong. PLoS One. 2015; 10: e122406.
26. Wu SJ, Zhu GQ, Ye BZ, Kong FQ, Zheng ZX, Zou H, et al. Association between sex-specific serum uric acid and non-alcoholic fatty liver disease in Chinese adults: a large population-based study. Medicine (Baltimore). 2015; 94: e802.
27. Sun W, Zhang D, Sun J, Xu B, Sun K, Wang T, et al. Association between non-alcoholic fatty liver disease and autonomic dysfunction in a Chinese population. QJM. 2015; 108: 617-624. doi: 10.1093/qjmed/hcv006 PMID: 25614616
28. Yang CQ, Shu L, Wang S, Wang JJ, Zhou Y, Xuan YJ, et al. Dietary Patterns Modulate the Risk of Non-Alcoholic Fatty Liver Disease in Chinese Adults. Nutrients. 2015; 7: 4778-4791. doi: 10.3390/nu7064778 PMID: 26083112
29. Day CP. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol. 2002; 16: 663-678. PMID: 12406438
30. Gambino R, Musso G, Cassader M. Redox balance in the pathogenesis of nonalcoholic fatty liver disease: mechanisms and therapeutic opportunities. Antioxid Redox Signal. 2011; 15: 1325-1365. doi: 10.1089/ars.2009.3058 PMID: 20969475
31. Valdecantos MP, Perez-Matute P, Quintero P, Martinez JA. Vitamin C, resveratrol and lipoic acid actions on isolated rat liver mitochondria: all antioxidants but different. Redox Rep. 2010; 15: 207-216. doi: 10.1179/135100010X12826446921464 PMID: 21062536
32. Aasheim ET, Hofso D, Hjelmesaeth J, Birkeland KI, Bohmer T. Vitamin status in morbidly obese patients: a cross-sectional study. Am J Clin Nutr. 2008; 87: 362-369. PMID: 18258626
33. Mah E, Matos MD, Kawiecki D, Ballard K, Guo Y, Volek JS, et al. Vitamin C status is related to proinflammatory responses and impaired vascular endothelial function in healthy, college-aged lean and obese men. J Am Diet Assoc. 2011; 111: 737-743. doi: 10.1016/j.jada.2011.02.003 PMID: 21515122
34. Kim JY, van de Wall E, Laplante M, Azzara A, Trujillo ME, Hofmann SM, et al. Obesity-associated improvements in metabolic profile through expansion of adipose tissue. J Clin Invest. 2007; 117: 2621-2637. PMID: 17717599
35. Rose FJ, Webster J, Barry JB, Phillips LK, Richards AA, Whitehead JP. Synergistic effects of ascorbic acid and thiazolidinedione on secretion of high molecular weight adiponectin from human adipocytes. Diabetes Obes Metab. 2010; 12: 1084-1089. doi: 10.1111/j.1463-1326.2010.01297.x PMID: 20977580
36. Ginter E. Ascorbic acid in cholesterol and bile acid metabolism. Ann N Y Acad Sci. 1975; 258: 410-421. PMID: 1060410
37. Nambisan B, Kurup PA. Ascorbic acid and glycosaminoglycan and lipid metabolism in guinea pigs fed normal and atherogenic diets. Atherosclerosis. 1975; 22: 447-461. PMID: 128367
38. Rezazadeh A, Yazdanparast R, Molaei M. Amelioration of diet-induced nonalcoholic steatohepatitis in rats by Mn-salen complexes via reduction of oxidative stress. J Biomed Sci. 2012; 19: 26. doi: 10.1186/1423-0127-19-26 PMID: 22375551
39. Harrison SA, Torgerson S, Hayashi P, Ward J, Schenker S. Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis. Am J Gastroenterol. 2003; 98: 2485-2490. PMID: 14638353
40. Foster T, Budoff MJ, Saab S, Ahmadi N, Gordon C, Guerci AD. Atorvastatin and antioxidants for the treatment of nonalcoholic fatty liver disease: the St Francis Heart Study randomized clinical trial. Am J Gastroenterol. 2011; 106: 71-77. doi: 10.1038/ajg.2010.299 PMID: 20842109
41. Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F, Marcellini M. Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2006; 24: 1553-1561. PMID: 17206944
42. Nobili V, Manco M, Devito R, Di Ciommo V, Comparcola D, Sartorelli MR, et al. Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology. 2008; 48: 119-128. doi: 10.1002/hep.22336 PMID: 18537181
43. Papandreou D, Rousso I, Mavromichalis I. Update on non-alcoholic fatty liver disease in children. Clin Nutr. 2007; 26: 409-415. PMID: 17449148
44. Zhang ZC, Liu Y, Xiao LL, Li SF, Jiang JH, Zhao Y, et al. Up-regulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice. J Hepatol. 2015.
45. Veena J, Muragundla A, Sidgiddi S, Subramaniam S. Non-alcoholic fatty liver disease: need for a balanced nutritional source. Br J Nutr. 2014; 112: 1858-1872. doi: 10.1017/S0007114514002591 PMID: 25274101
46. Jankovic A, Korac A, Srdic-Galic B, Buzadzic B, Otasevic V, Stancic A, et al. Differences in the redox status of human visceral and subcutaneous adipose tissues-relationships to obesity and metabolic risk. Metabolism. 2014; 63: 661-671. doi: 10.1016/j.metabol.2014.01.009 PMID: 24582138
47. Uzun H, Zengin K, Taskin M, Aydin S, Simsek G, Dariyerli N. Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding. Obes Surg. 2004; 14: 659-665. PMID: 15186635
48. Canbakan B, Senturk H, Tahan V, Hatemi I, Balci H, Toptas T, et al. Clinical, biochemical and histological correlations in a group of non-drinker subjects with non-alcoholic fatty liver disease. Acta Gastroenterol Belg. 2007; 70: 277-284. PMID: 18074737